Inhibition of retinoic acid receptor function in normal human mammary epithelial cells results in increased cellular proliferation and inhibits the formation of a polarized epithelium in vitro

Experimental Cell Research

Volumn 236, Issue 1, 1997, Pages 16-28

  Seewaldt, Victoria L ^a   Caldwell, L Elizabeth ^b   Johnson, Barton S ^a   Swisshelm, Karen ^a   Collins, Steven J ^a   Tsai, Schickwann ^b  

^a UNIVERSITY OF WASHINGTON   (United States)

^b Fred Hutchinson Cancer Research Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

RETINOIC ACID; RETINOIC ACID RECEPTOR;

ARTICLE; BREAST CANCER; BREAST CARCINOGENESIS; BREAST EPITHELIUM; CELL CYCLE; CELL PROLIFERATION; CONTROLLED STUDY; EPITHELIUM CELL; GROWTH INHIBITION; GROWTH REGULATION; HUMAN; HUMAN CELL; PRIORITY JOURNAL;

ATRA;

EID: 0031563775     PISSN: 00144827     EISSN: None     Source Type: Journal    
DOI: 10.1006/excr.1997.3694     Document Type: Article

References (56)

1. 1. Gudas, L. J. (1992) Retinoids, retinoid-responsive genes, cell differentiation, and cancer. Cell Growth Differ. 3, 655-662.
2. 2. Love, J. M., and Gudas, L. J. (1994) Vitamin A, differentiation and cancer. Curr. Opin. Cell Biol. 6, 825-831.
3. 3. Hong, W. K., Lippman, S. M., Itiri, L. M., Karp, D. D., Lee, J. S., Byers, R. M., Schantz, S. P., Kramer, A. M., Lotan, R., Peters, L. J., Dimery, I. W., Brown, B. W., and Goepfert, H. (1990) Prevention of second primary tumors with isotretinoin in squamous-cell carcinoma of the head and neck. N. Engl. J. Med. 323, 795-801.
4. 4. Smith, M. A., Parkinson, D. R., Cheson, B. D., and Friedman, M. A. (1992) Retinoids in cancer therapy. J. Clin. Oncol. 10, 839-864.
5. 5. Lippman, S. M., Bataskis, J. G., Toth, B. B., Weber, R. S., Lee, J. J., Martin, J. W., Hays, G. L., Goepfert, H., and Hong, W. K. (1993) Comparison of low-dose isotretinoin with beta-carotene to prevent oral carcinogenesis. N. Engl. J. Med. 328, 15-20.
6. 6. Pastorino, U., Infante, M., Maioli, M., Chiesa, G., Buyse, M., Firket, P., Rosmentz, N., Clerici, M., Soresi, E., Valente, M., Belloni, P. A., and Ravasi, G. (1993) Adjuvant treatment of stage I lung cancer with high-dose vitamin A. J. Clin. Oncol. 11, 1216-1222.
7. 7. Benner, S. E., Pajak, T. F., Lippman, S. M., and Hong, W. K. (1994) Prevention of second primary tumors with isotretinoin in patients with squamous cell carcinoma of the head and neck: Long-term follow-up. J. Natl. Cancer Inst. 86, 140-141.
8. 8. Chambon, P. (1994) The retinoid signalling pathway: Molecular and genetic analyses. Semin. Cell. Biol. 5, 115-125.
9. 9. Chiesa, F., Tradati, N., Marazza, M., Rossi, N., Boracchi, P., Mariani, L., Clerici, M., Formelli, F., Barzan, L., and Carrassi, A. (1994) Prevention of local relapses and new localizations of oral leukoplakia with the synthetic retinoid fenretinide (4-HPR): Preliminary results. Eur. J. Cancer 28B, 97-102.
10. 10. Hong, W. K., and Itri, L. M. Retinoids and human cancer. (1994) in The Retinoids: Biology, Chemistry, and Medicine (Sporn, M. B., Roberts, A. B., and Goodman, D. S., Eds.), pp. 597-658, Raven Press, New York.
11. 11. Lippman, S. M., Benner, S. E., and Hong, W. K. (1994) Cancer chemoprevention. J. Clin. Oncol. 12, 851-873.
12. 12. Meyskens, F. L., Jr., Surwit, E., Moon, T. E., Childers, J. M., Davis, J. R., Dorr, R. T., Johnson, C. S., and Alberts, D. S. (1994) Enhancement of regression of cervical intraepithelial neoplasia II (moderate dysplasia) with topically applied all-trans-retinoic acid: A randomized trial. J. Natl. Cancer Inst. 86, 539-543.
13. 13. Vokes, E. E., Weichselbaum, R. R., Lippman, S. M., and Hong, W. K. (1993) Head and neck cancer. N. Engl. J. Med. 328, 184-194.
14. 14. Hunter, D. J., Manson, J. E., Colditz, G. A., Stampfer, M. J., Rosner, B., Hennekens, C. H., Speizer, F. E., and Willett, W. C. (1993) A prospective study of the intake of vitamins C, E, and A and the risk of breast cancer. N. Engl. J. Med. 329, 234-240.
15. 15. Costa, A., De Palo, G., Decensi, A., Formelli, F., Chiesa, F., Nava, M., Camerini, T., Marubini, E., and Veronesi, U. (1995) Retinoids in cancer and chemoprevention. Clinical trials with the synthetic analogue fenretinide. Ann. N.Y. Acad. Sci. 768, 148-162.
16. 16. De Palo, G., Veronesi, U., Marubini, E., Camerini, T., Chiesa, F., Nava, M., Formelli, F., Del Vecchio, M., Costa, A., and Boracchi, P. (1995) Controlled clinical trials with fenretinide in breast cancer, basal cell carcinoma, and oral leukoplakia. J. Cell. Biochem. Suppl. 22, 11-17.
17. 17. Giguere, V., Ong, E. S., Segui, P., and Evan, R. M. (1987) Identification of a receptor for the morphogen retinoic acid. Nature 330, 624-629.
18. 18. Petkovich, M., Brand, N. J., Krust, A., and Chambon, P. (1987) A human retinoic acid receptor which belongs to the family of nuclear receptors. Nature 330, 444-450.
19. 19. Benbrook, D., Lernhardt, E., and Pfahl, M. (1988) A new retinoic acid receptor identified from a hepatocellular carcinoma. Nature 333, 669-672.
20. 20. Brand, N., Petkovich, M., Krust, A., Chambon, P., de The, H., Marchio, A., Tiollais, P., and Dejean, A. (1988) Identification of a second human retinoic acid receptor. Nature 332, 850-853.
21. 21. Krust, A., Kastner, P., Petkovich, M., Zelent, A., and Chambon, P. (1989) A third human retinoic acid receptor, hRARγ. Proc. Natl. Acad. Sci. USA 86, 5310-5314.
22. 22. de The, H., del Mar Vivanco-Ruiz, M., Tiollais, P., Stunnenberg, H., and Dejean, A. (1990) Identification of a retinoic acid receptor-β gene. Nature 343, 177-180.
23. 23. Hoffmann, B., Lehmann, J. M., Zhang, X.-K., Hermann, T., Husmann, M., Graupner, G., and Pfahl, M. (1990) A retinoic acid receptor-specific element controls the retinoic acid receptor-β promoter. Mol. Endocrinol. 4, 1727-1736.
24. 24. Gerbert, J. F., Moghal, N., Frangioni, J. V., Sugarbaker, D. J., and Neel, B. G. (1991) High frequency of retinoic acid receptor-β abnormalities in human lung cancer. Oncogene 6, 1859-1868.
25. 25. Houle, B., Leduc, F., and Bradley, W. E. C. (1991) Implications of the RARβ in epidermoid (squamous) lung cancer. Genes Chromosomes Cancer 3, 358-366.
26. 26. Hu, L., Crowe, D., Rheinwald, J. G., Chambon, P., and Gudas, L. J. (1991) Abnormal expression of retinoic acid receptors and keratin 19 by human oral and epidermal squamous cell lines. Cancer Res. 51, 3972-3981.
27. 27. Roman, S. D., Clarke, C. L., Hall, R. E., Alexander, I. E., and Sutherland, R. L. (1992) Expression and regulation of retinoic acid receptors in human breast cancer cells. Cancer Res. 52, 2236-2242.
28. 28. Houle, B., Rochette-Egly, C., and Bradley, W. E. C. (1993) Tumor-suppressive effect of the retinoic acid receptor-β in human epidermoid lung cancer cells. Proc. Natl. Acad. Sci. USA 90, 958-989.
29. 29. van der Berg, B., van der Leede, B.-j., Kwakkenbos-Isbrucker, L., Salverda, S., de Laat, S. W., and van der Saag, P. T. (1993) Retinoic acid resistance of estradiol-independent breast cancer cell lines coincides with diminished retinoic acid receptor function. Mol. Cell. Endocrinol. 91, 149-157.
30. 30. Swisshelm, K., Ryan, K., Lee, X., Tsou, H. C., Peacocke, M., and Sager, R. (1994) Down-regulation of a retinoic acid receptor-β in mammary carcinoma cell lines and its up-regulation in senescing normal mammary epithelial cells. Cell Growth Differ. 5, 133-141.
31. 31. Seewaldt, V. L., Johnson, B. S., Parker, M. B., Collins, S. J., and Swisshelm, K. (1995) Expression of retinoic acid receptor β mediates retinoid-induced growth arrest and apoptosis in breast cancer cells. Cell Growth Differ. 6, 1077-1088.
32. 1 arrest but not apoptosis of normal human mammary epithelial cells. Cell Growth Differ. 8, 631-641.
33. 33. Tsai, S., Bartelmez, S., Heyman, R., Damm, K., Evans, R., and Collins, S. J. (1992) A mutated retinoic acid receptor-alpha exhibiting dominant-negative activity alters the lineage development of a multipotent hematopoietic cell line. Genes Dev. 6, 2258-2269.
34. 34. Tsai, S., and Collins, S. J. (1993) A dominant negative retinoic acid receptor blocks neutrophil differentiation at the promyelocytic stage. Proc. Natl. Acad. Sci. USA 90, 7153-7157.
35. 35. Tsai, S., Bartelmez, S., Sitnicka, E., and Collins, S. (1994) Lymphohematopoietic progenitors immortalized by a retroviral vector harboring a dominant-negative retinoic acid receptor can recapitulate lymphoid, myeloid, and erythroid development. Genes Dev. 8, 2831-2841.
36. 36. Anderson, B., and Rosenfield, M. G. (1995) New wrinkles in retinoids. Nature 374, 118-119.
37. 37. Imakado, S., Bickenbach, J. R., Bundman, D. S., Rothnagel, J. A., Attar, P. S., Wang, X.-J., Walcznak, V. R., Wisniewski, S., Pote, J., Gordon, J. S., Heyman, R. A., Evans, R. M., and Roop, D. R. (1995) Targeting expression of a dominant-negative retinoic acid receptor mutant in the epidermis of transgenic mice results in loss of barrier function. Genes Dev. 9, 317-328.
38. 38. Saitou, M., Sugai, S., Tanaka, T., Shimouchi, K., Fuchs, E., Narumiya, S., and Kakizuka, A. (1995) Inhibition of skin development by targeted expression of a dominant-negative retinoic acid receptor. Nature 374, 159-162.
39. 39. Damm, K., Heyman, R. A., Umesono, K., and Evans, R. M. (1993) Functional inhibition of retinoic acid response by dominant negative retinoic acid receptor mutants. Proc. Natl. Acad. Sci. USA 90, 2989-2993.
40. 40. Stampfer, M. (1985) Isolation and growth of human mammary epithelial cells. J. Tissue Cult. Methods 9, 107.
41. 41. Russell, W. C., Newman, C., and Williamson, D. H. (1975) A simple cytochemical technique for demonstration of DNA in cells infected with mycoplasmas and viruses. Nature 253, 461-462.
42. 42. Rio, M. C., Bellocq, J. P., Gairard, B., Rasmussen, U. B., Krust, A., Koehl, C., Calderoli, H., Schiff, V., Renaud, R., and Chambon, P. (1987) Specific expression of the pS2 gene in subclasses of breast cancer in comparison with expression of the estrogen and progesterone receptors and the oncogene ERBB2. Proc. Natl. Acad. Sci. USA 84, 9243-9247.
43. 43. Geballe, A., Spate, R., and Mocarski, E. (1986) A cis-acting element within the 5′ leader of a cytomegalovirus beta transcript determines kinetic class. Cell 46, 865-876.
44. 44. Folkman, J., and Moscona, A. (1978) Role of cell shape in growth control. Nature 273, 345-349.
45. 45. Streuli, C. H., Bailey, N., and Bissell, M. J. (1991) Control of mammary epithelial differentiation: Basement membrane induces tissue-specific gene expression in the absence of cell-cell interactions and morphologic polarity. J. Cell. Biol. 115, 1383-1395.
46. 46. Karnovsky, M. J. (1965) A formaldehyde fixative of high osmolarity for use in electron microscopy. J. Cell. Biol. 27, 137.
47. 47. Petersen, O. W., Ronnov-Jessen, L., Hewlett, A. R., and Bissell, M. J. (1992) Interaction with basement membrane serves to rapidly distinguish growth and differentiation pattern of normal and malignant human breast epithelial cells. Proc. Natl. Acad. Sci. USA 89, 9064-9068.
48. 48. Hewlett, A. R., Petersen, O. W., Steeg, P. S., and Bissell, M. J. (1994) A novel function for the nm23-H1 gene: Overexpression in human breast cancer carcinoma cells leads to the formation of basement membrane and growth arrest. J. Natl. Cancer Inst. 86, 1838-1843.
49. 49. Roskelly, C. D., Deprez, P. Y., and Bissell, M. J. (1994) Extracellular matrix-dependent tissue-specific gene expression in mammary epithelial cells requires both physical and biochemical signal transduction. Proc. Natl. Acad. Sci. USA 91, 12378-12382.
50. 50. Stampfer, M. R., and Yaswen, P. (1994) Growth, differentiation and transformation of human mammary epithelial cells in culture. in Mammary Tumorigenesis and Malignant Progression (Dickenson, R., and Lippman, M., Eds.), pp. 29-47, Kluwer, Dordrecht.
51. 51. Lochter, A., and Bissell, M. J. (1995) Involvement of extracellular matrix constituents in breast cancer. Semin. Cancer Biol. 6, 165-173.
52. 52. Kastner, P., Grondona, J. M., Mark, M., Gansmuller, A., Le Mur, M., Decimo, D., Vonesch, J.-L., Dolle, P., and Chambon, P. (1994) Genetic analysis of RXR alpha developmental function: Convergence of RXR and RAR signaling pathways in heart and eye morphogenesis. Cell 78, 987-1003.
53. 53. Mendelsohn, C., Mark, P., Dolle, P., Dieerich, A., Gaub, M. P., Krust, A., Lampron, C., and Chambon, P. (1994) Retinoic acid receptor β2 (RARβ2) null mutant mice appear normal. Dev. Biol. 166, 246-258.
54. 54. van der Berg, B., van der Leede, B.-J., M., Kwakkenbos-Isbrucker, L., Salverda, S., de Laat, S. W., and van der Saag, P. T. (1993) Retinoic acid resistance of estradiol-independent breast cancer cell lines coincides with diminished retinoic acid receptor function. Mol. Cell. Endocrinol. 91, 149-157.
55. 55. Lotan, R. (1996) Clinical applications of retinoids in prevention and treatment of malignancies. FASEB J. 10, 1031-1039.
56. 56. Lotan, R., Xu, X.-C., Lippman, S. M., Ro, J. Y., Lee, J. S., Lee, J. J., and Hong, W. K. (1995) Suppression of retinoic acid receptor-β in premalignant oral lesions and its up-regulation by isotretinoin. N. Engl. J. Med. 332, 1405-1410.